Haute Capital Partners SA (BX Swiss : HAUTE) informs the market that FINMA (Swiss Financial Market Supervisory Authority) has opened enforcement proceedings against the company and its CEO, Thibault Leroy Bürki, pursuant to Art. 53 FINMASA.

Haute Capital Partners SA (BX Swiss: HAUTE) is pleased to announce a strategic investment of CHF 500’000 in footbao.world ag (footbao.world), a Swiss technology company headquartered in Zug. The investment is structured as a convertible loan agreement.

Haute Capital Partners portfolio company BioCopy AG has released the first public description of ValidaTe®, its AI-driven discovery platform for safer cancer immunotherapies.

The ETH Zurich spin-off extends its seed financing three years after the CHF 1.8 million round led by Haute Capital Partners.